Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Melasma
and you are
between 20 and 60
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Tri-split face study of skin resurfacing modalities for the treatment of melasma, comparing the medium depth trichloroacetic acid peel, CO2 laser and Qs-NdYag laser.

Provided treatments

  • Drug: 22% TCA peel
  • Device: CO2 laser
  • Device: Qs-NdYag laser
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02892071. The sponsor of the trial is SUZAN OBAGI and it is looking for 20 volunteers for the current phase.
Official trial title:
Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma